Use of BioSense for Rapid Assessment of the Safety of Medical Countermeasures

Authors

  • Ralph J. Coates Division of Notifiable Diseases and Healthcare Information, Centers for Disease Control and Prevention
  • Kathleen Gallagher Division of Notifiable Diseases and Healthcare Information, Centers for Disease Control and Prevention

DOI:

https://doi.org/10.5210/ojphi.v5i1.4564

Abstract

Surveillance systems to monitor the safety of drugs and vaccinations have limited ability to monitor safety of medical countermeasures (MCM). To examine the potential for using BioSense data to monitor and rapidly assess the safety of MCM, the authors reviewed literature and characteristics of BioSense data and consulted experts. Use of BioSense data for this purpose has potential, but a number of issues need further evaluation.

Author Biography

Ralph J. Coates, Division of Notifiable Diseases and Healthcare Information, Centers for Disease Control and Prevention

Ralph Coates is an epidemiologist working with the BioSense program and is a member of an interagency workgroup examining the potential for public health surveillance systems to contribute to the surveillance of the safety and effectiveness of medical countermeasures.

Downloads

Published

2013-03-24

How to Cite

Coates, R. J., & Gallagher, K. (2013). Use of BioSense for Rapid Assessment of the Safety of Medical Countermeasures. Online Journal of Public Health Informatics, 5(1). https://doi.org/10.5210/ojphi.v5i1.4564

Issue

Section

Oral Presentations: System Resources and Assessment